Vertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...

Real-time index price for S&P 500 Index (INX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

The U.S. hedge fund, which manages around $70 billion in assets, is one of Wall Street's most influential investors, known for pressuring companies to fire management, break apart and spin off ...

Google today announced updates to Gemini, the company's AI product that competes with OpenAI's ChatGPT, DeepSeek, and Apple Intelligence.

Google DeepMind announced today updates to its Gemini 2.0 models, including dropping Gemini 2.0 Flash-Lite, which is faster ...

To precache or to bundle your PSOs, that is the question. Fortunately, Epic has the answer, too.

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...

Apple stock rises after the tech giant posts better-than-expected earnings and guides for solid growth, Intel edges higher after revenue projections miss analysts’ estimates, and Chevron posts ...

U.S. stocks fall on Friday after the White House says Canada, Mexico and China tariffs will start Saturday. Still, major ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

A new neural network process has designed wireless chips that can outperform existing ones. This convolutional neural network analyzes the desired chip properties then designs backward.

Analyst Michael Yee of Jefferies maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), retaining the price target of $550.00. Michael Yee’s rating is based on Vertex ...